R&D Systems™ Recombinant Human IL-35 Fc Chimera Protein

Catalog No.	Quantity
86-08I-L050	50 μg

Catalog No. 86-08I-L050 Supplier R&D Systems™ Supplier No. 8608IL050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-35 Fc Chimera Protein is derived from HEK293. The Recombinant Human IL-35 Fc Chimera Protein has been validated for the following applications: Bioactivity.

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.

Specifications

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 10148
• Molecular Weight (g/mol): Observed M.W.: 81-97kDa, reducing conditions, Theoretical M.W.: 73kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human IL-35 protein Human IL-27 beta/EBI3 (Arg21-Lys229) Accession &Num; Q14213 (GGGS)4 Human IL-12 alpha/p35 Arg23-Ser219 Accession &Num; P29459 IEGRMD Human IgG1 Pro100-Lys330)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Common Name: IL-35
• Gene Symbol: EBI3
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human IL-12 R beta 2 Fc Chimera is immobilized at 5μg/mL (100μL/well), the concentration of Recombinant Human IL-35 Fc Chimera that produces 50% optimal binding response is approximately 20-120ng/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Human embryonic kidney cell, HEK293-derived Human IL-27 beta/EBI3 (Arg21-Lys229) Accession # Q14213, N-terminus; (GGGS)4; Human IL-12 alpha/p35 Arg23-Ser219 Accession # P29459; IEGRMD; Human IgG1 Pro100-Lys330), C-terminus
• Purity or Quality Grade: >80%, by SDS-PAGE under reducing conditions and visualized by silver stain